Folic acid deficiency: main etiological factor of megaloblastic anemia in Kazakhstan? [2]

American Journal of Hematology

Volumn 81, Issue 6, 2006, Pages 471-

  Akilzhanova, Ainur ^a   Takamura, Noboru ^b   Aoyagi, Kiyoshi ^b   Karazhanova, Ludmila ^a   Yamashita, Shunichi ^b,c  

^a SEMEY MEDICAL UNIVERSITY   (Kazakhstan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID;

ADULT; AGED; ANISOCYTOSIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIETARY INTAKE; ERYTHROCYTE DISORDER; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; KAZAKHSTAN; LETTER; MEGALOBLASTIC ANEMIA; MEGALOCYTOSIS; POIKILOCYTOSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, MEGALOBLASTIC; FEMALE; FOLIC ACID DEFICIENCY; HUMANS; KAZAKHSTAN; MALE; MIDDLE AGED;

EID: 33646886423     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20576     Document Type: Letter

References (5)

1. Sullivan LW. The differential diagnosis and management of the patients with megaloblastic anemia. Am J Med 1970;48:609-617.
2. th edition. Washington, D.C.: The Nutrition Foundation; 1984. p 347-364.
3. 12 transport and the related diseases. Clin Biochem 1984;17:99-107.
4. Verhoef P, Kok FJ, Kruyssen DACM, et al. Plasma total homocysteine, B vitamins and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:989-995.
5. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-1781.